Trial Profile
A Single-centre, Randomised, Placebo-controlled, Double-blind Single Dose, Dose Escalation Trial Investigating Safety, Pharmacokinetics and Local Tolerability of Ascending Subcutaneous Doses of Long Acting-rFVIIa in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 May 2016
Price :
$35
*